These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181 [Abstract] [Full Text] [Related]
8. Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience. Mastrobuoni S, Ubilla M, Cordero A, Herreros J, Rabago G. Transplant Proc; 2007 Sep 15; 39(7):2163-6. PubMed ID: 17889125 [Abstract] [Full Text] [Related]
9. Morbidity rates with reduced mycophenolate mofetil dosage: a single-center experience. Kaushik M, Kay MD, Bagul A, Nicholson ML. Transplant Proc; 2006 Nov 15; 38(9):2864-5. PubMed ID: 17112850 [Abstract] [Full Text] [Related]
15. Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario. Srivastava A, Singh V, Kumar A, Sharma RK, Gupta A. Transplant Proc; 2004 Sep 15; 36(7):2060-4. PubMed ID: 15518746 [Abstract] [Full Text] [Related]
20. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Wiesner R, Rabkin J, Klintmalm G, McDiarmid S, Langnas A, Punch J, McMaster P, Kalayoglu M, Levy G, Freeman R, Bismuth H, Neuhaus P, Mamelok R, Wang W. Liver Transpl; 2001 May 15; 7(5):442-50. PubMed ID: 11349266 [Abstract] [Full Text] [Related] Page: [Next] [New Search]